2012
DOI: 10.5858/arpa.2011-0056-rs
|View full text |Cite
|
Sign up to set email alerts
|

Aggressive Angiomyxoma

Abstract: Aggressive angiomyxoma is a rare mesenchymal tumor that most commonly arises in the vulvovaginal region, perineum, and pelvis of women. The term aggressive emphasizes the often infiltrative nature of the tumor and its frequent association with local recurrence. Patients often present with nonspecific symptoms which are frequently misdiagnosed with more common entities, such as a Bartholin cyst, lipoma, or hernia. Histologic examination reveals a hypocellular and highly vascular tumor with a myxoid stroma conta… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

6
172
0
7

Year Published

2013
2013
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 132 publications
(185 citation statements)
references
References 28 publications
6
172
0
7
Order By: Relevance
“…Estrogen and progesterone receptors are also detected in some cases. Mainly because of the benign characters, the recurrent tumor has similar features with the primary one [1,9,10].…”
Section: Figure 4bmentioning
confidence: 99%
“…Estrogen and progesterone receptors are also detected in some cases. Mainly because of the benign characters, the recurrent tumor has similar features with the primary one [1,9,10].…”
Section: Figure 4bmentioning
confidence: 99%
“…It can be positive for estrogen and progesterone receptors and it has been noted that there may be a chromosomal translocation at 12q13-15 band involving the High Mobility Group AT-Hook 2 (HMGA2) gene. Due to the tumor cells being positive for estrogen and progesterone receptors, some cases have been reported being responsive to Gonadotropin-releasing hormone (GnRH) agonist [2].…”
Section: Discussionmentioning
confidence: 99%
“…Насколько это критично? В проведенных ранее исследованиях [1,14] показано, что максимально радикальное и неполное удаление опухоли даже без проведения лучевой и химиотера-пии одинаково часто сопровождается рецидивом опухолевого роста -до 30-40%. В связи с этим все пациенты, независимо от размеров опухоли и объема проведенной операции, подлежат наблюдению на протяжении продолжительного времени (десятиле-тия) с проведением МРТ в динамике.…”
Section: Discussionunclassified